Mechanisms of drug resistance: Quinolone resistance

Annals of the New York Academy of Sciences

Volumn 1354, Issue 1, 2015, Pages 12-31

  Hooper, David C ^a,c   Jacoby, George A ^b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

DNA gyrase; Efflux pumps; Plasmids; Quinolone; Topoisomerase

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE (ATP HYDROLYSING) B; DNA TOPOISOMERASE IV; PROTEIN PARE; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MEMBRANE; BACTERIAL STRAIN; DRUG BINDING; DRUG PENETRATION; GENE EXPRESSION REGULATION; GENE MUTATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PLASMID; REGULATOR GENE; BACTERIAL INFECTION; BACTERIUM; DRUG EFFECTS; GENETICS; MICROBIOLOGY; MUTATION;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; HUMANS; MUTATION; QUINOLONES;

EID: 84945444280     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.12830     Document Type: Article

References (245)

1. Owens, R.C., Jr. & P.G. Ambrose . 2000. Clinical use of the fluoroquinolones. Med. Clin. North Am. 84: 1447-1469.
2. Kim, E.S. & D.C. Hooper . 2014. Clinical importance and epidemiology of quinolone resistance. Infect. Chemother. 46: 226-238.
3. Lesher, G.Y., E.D. Forelich, M.D. Gruet, et al. 1962. 1, 8-Naphthyridine derivatives. A new class of chemotherapeutic agents. J. Med. Pharm. Chem. 5: 1063-1068.
4. Domagala, J.M. & S.E. Hagen . 2003. Structure-activity relationships of the quinolone antibacterials in the new millennium: some things change and some do not. In Quinolone Antimicrobial Agents. 3rd ed. D.C. Hooper & E. Rubinstein, Eds.: 3-18. Washington, DC: ASM Press.
5. Hooper, D.C. 1997. Bacterial topoisomerases, anti-topoisomerases, and anti-topoisomerase resistance. Clin. Infect. Dis. 27: S54-S63.
6. Wang, J.C. 1996. DNA topoisomerases. Annu. Rev. Biochem. 65: 635-692.
7. Aldred, K.J., R.J. Kerns & N. Osheroff . 2014. Mechanism of quinolone action and resistance. Biochemistry 53: 1565-1574.
8. Drlica, K., H. Hiasa, R. Kerns, et al. 2009. Quinolones: action and resistance updated. Curr. Top. Med. Chem. 9: 981-998.
9. Drlica, K. & X.L. Zhao . 1997. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Rev. 61: 377-392.
10. Hiasa, H., D.O. Yousef & K.J. Marians . 1996. DNA strand cleavage is required for replication fork arrest by a frozen topoisomerase-quinolone-DNA ternary complex. J. Biol. Chem. 271: 26424-26429.
11. Morais Cabral, J.H., A.P. Jackson, C.V. Smith, et al. 1997. Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 388: 903-906.
12. Wohlkonig, A., P.F. Chan, A.P. Fosberry, et al. 2010. Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance. Nat. Struct. Mol. Biol. 17: 1152-1153.
13. Laponogov, I., M.K. Sohi, D.A. Veselkov, et al. 2009. Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases. Nat. Struct. Mol. Biol. 16: 667-669.
14. Laponogov, I., D.A. Veselkov, I.M. Crevel, et al. 2013. Structure of an 'open' clamp type II topoisomerase-DNA complex provides a mechanism for DNA capture and transport. Nucl. Acids Res. 41: 9911-9923.
15. Yoshida, H., M. Bogaki, M. Nakamura, et al. 1990. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob. Agents Chemother. 34: 1271-1272.
16. Hooper, D.C. 2003. Mechanisms of quinolone resistance. In Quinolone Antimicrobial Agents. 3rd ed. D.C. Hooper & E. Rubinstein, Eds: 41-67. Washington, DC: ASM Press.
17. Yoshida, H., M. Nakamura, M. Bogaki, et al. 1993. Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob. Agents Chemother. 37: 839-845.
18. Willmott, C.J. & A. Maxwell . 1993. A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex. Antimicrob. Agents Chemother. 37: 126-127.
19. Willmott, C.J., S.E. Critchlow, I.C. Eperon, et al. 1994. The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase. J. Mol. Biol. 242: 351-363.
20. Aldred, K.J., S.A. McPherson, P. Wang, et al. 2012. Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance. Biochemistry 51: 370-381.
21. Hiasa, H. 2002. The Glu-84 of the ParC subunit plays critical roles in both topoisomerase IV-quinolone and topoisomerase IV-DNA interactions. Biochemistry 41: 11779-11785.
22. Yoshida, H., M. Bogaki, M. Nakamura, et al. 1991. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35: 1647-1650.
23. Breines, D.M., S. Ouabdesselam, E.Y. Ng, et al. 1997. Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of parE gene encoding a subunit of topoisomerase IV. Antimicrob. Agents Chemother. 41: 175-179.
24. Berger, J.M., S.J. Gamblin, S.C. Harrison, et al. 1996. Structure and mechanism of DNA topoisomerase II. Nature 379: 225-232.
25. Fass, D., C.E. Bogden & J.M. Berger . 1999. Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands. Nature Struct. Biol. 6: 322-326.
26. Mustaev, A., M. Malik, X. Zhao, et al. 2014. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding. J. Biol. Chem. 289: 12300-12312.
27. Fournier, B., X. Zhao, T. Lu, et al. 2000. Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis. Antimicrob. Agents Chemother. 44: 2160-2165.
28. Pan, X.S. & L.M. Fisher . 1997. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob. Agents Chemother. 41: 471-474.
29. Blanche, F., B. Cameron, F.X. Bernard, et al. 1996. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases. Antimicrob. Agents Chemother. 40: 2714-2720.
30. Trucksis, M., J.S. Wolfson & D.C. Hooper . 1991. A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus. J. Bacteriol. 173: 5854-5860.
31. Ng, E.Y., M. Trucksis & D.C. Hooper . 1996. Quinolone resistance mutations in topoisomerase IV: relationship of the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase the secondary target of fluoroquinolones in Staphylococcus aureus. Antimicrob. Agents Chemother. 40: 1881-1888.
32. Pan, X.S. & L.M. Fisher . 1999. Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones. Antimicrob. Agents Chemother. 43: 1129-1136.
33. Pan, X.S. & L.M. Fisher . 1998. DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42: 2810-2816.
34. Strahilevitz, J. & D.C. Hooper . 2005. Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin. Antimicrob. Agents Chemother. 49: 1949-1956.
35. Schmitz, F.J., M.E. Jones, B. Hofmann, et al. 1998. Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrob. Agents Chemother. 42: 1249-1252.
36. Tsukamura, M., E. Nakamura, S. Yoshii, et al. 1985. Therapeutic effect of a new antibacterial substance ofloxacin (DL8280) on pulmonary tuberculosis. Am. Rev. Resp. Dis. 131: 352-356.
37. Mégraud, F. 1998. Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 115: 1278-1282.
38. Li, X.Z. & H. Nikaido . 2009. Efflux-mediated drug resistance in bacteria: an update. Drugs 69: 1555-1623.
39. Grkovic, S., M.H. Brown & R.A. Skurray . 2002. Regulation of bacterial drug export systems. Microbiol. Mol. Biol. Rev. 66: 671-701.
40. Blair, J.M., V.N. Bavro, V. Ricci, et al. 2015. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity. Proc. Natl. Acad. Sci. U. S. A 112: 3511-3516.
41. Schindler, B.D., E. Frempong-Manso, C.E. DeMarco, et al. 2015. Analyses of multidrug efflux pump-like proteins encoded on the Staphylococcus aureus chromosome. Antimicrob Agents Chemother. 59: 747-748.
42. Ubukata, K., N. Itoh-Yamashita & M. Konno . 1989. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 33: 1535-1539.
43. Yu, J.L., L. Grinius & D.C. Hooper . 2002. NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes. J. Bacteriol. 184: 1370-1377.
44. Truong-Bolduc, Q.C., P.M. Dunman, J. Strahilevitz, et al. 2005. MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J. Bacteriol. 187: 2395-2405.
45. Truong-Bolduc, Q.C., J. Strahilevitz & D.C. Hooper . 2006. NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus. Antimicrob. Agents Chemother. 50: 1104-1107.
46. Ingavale, S., W. Van Wamel, T.T. Luong, et al. 2005. Rat/MgrA, a regulator of autolysis, is a regulator of virulence genes in Staphylococcus aureus. Infect. Immun. 73: 1423-1431.
47. Truong-Bolduc, Q.C., Y. Ding & D.C. Hooper . 2008. Posttranslational modification influences the effects of MgrA on norA expression in Staphylococcus aureus. J. Bacteriol. 190: 7375-7381.
48. Truong-Bolduc, Q.C. & D.C. Hooper . 2010. Phosphorylation of MgrA and its effect on expression of the NorA and NorB efflux pumps of Staphylococcus aureus. J. Bacteriol. 192: 2525-2534.
49. Truong-Bolduc, Q.C., G.R. Bolduc, R. Okumura, et al. 2011. Implication of the NorB efflux pump in the adaptation of Staphylococcus aureus to growth at acid pH and in resistance to moxifloxacin. Antimicrob. Agents Chemother. 55: 3214-3219.
50. Truong-Bolduc, Q.C., C.-H. Liao, R. Villet, et al. 2012. Reduced aeration affects the expression of the NorB efflux pump of Staphylococcus aureus by posttranslational modification of MgrA. J. Bacteriol. 194: 1823-1834.
51. Chen, P.R., T. Bae, W.A. Williams, et al. 2006. An oxidation-sensing mechanism is used by the global regulator MgrA in Staphylococcus aureus. Nat. Chem. Biol. 2: 591-595.
52. Ding, Y., Y. Onodera, J.C. Lee, et al. 2008. NorB, an efflux pump in Staphylococcus aureus MW2, contributes to bacterial fitness in abscesses. J. Bacteriol. 190: 7123-7129.
53. Truong-Bolduc, Q.C., P.M. Dunman, T. Eidem, et al. 2011. Transcriptional profiling analysis of the global regulator NorG, a GntR-like protein of Staphylococcus aureus. J. Bacteriol. 193: 6207-6214.
54. Truong-Bolduc, Q.C. & D.C. Hooper . 2007. Transcriptional regulators NorG and MgrA modulate resistance to both quinolones and β-lactams in Staphylococcus aureus. J. Bacteriol. 189: 2996-3005.
55. Fournier, B., A. Klier & G. Rapoport . 2001. The two-component system ArlS-ArlR is a regulator of virulence gene expression in Staphylococcus aureus. Mol. Microbiol. 41: 247-261.
56. Fournier, B. & D.C. Hooper . 2000. A new two-component regulatory system involved in adhesion autolysis, and extracellular proteolytic activity of Staphylococcus aureus. J. Bacteriol. 182: 3955-3964.
57. Huang, J., P.W. O'Toole, W. Shen, et al. 2004. Novel chromosomally encoded multidrug efflux transporter MdeA in Staphylococcus aureus. Antimicrob. Agents Chemother. 48: 909-917.
58. Yamada, Y., K. Hideka, S. Shiota, et al. 2006. Gene cloning and characterization of SdrM, a chromosomally-encoded multidrug efflux pump, from Staphylococcus aureus. Biol Pharm. Bull. 29: 554-556.
59. Nakaminami, H., N. Noguchi & M. Sasatsu . 2010. Fluoroquinolone efflux by the plasmid-mediated multidrug efflux pump QacB variant QacBIII in Staphylococcus aureus. Antimicrob. Agents Chemother. 54: 4107-4111.
60. Floyd, J.L., K.P. Smith, S.H. Kumar, et al. 2010. LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus. Antimicrob. Agents Chemother. 54: 5406-5412.
61. Kaatz, G.W., C.E. DeMarco & S.M. Seo . 2006. MepR, a repressor of the Staphylococcus aureus MATE family multidrug efflux pump MepA, is a substrate-responsive regulatory protein. Antimicrob. Agents Chemother. 50: 1276-1281.
62. Schindler, B.D., D. Patel, S.M. Seo, et al. 2013. Mutagenesis and modeling to predict structural and functional characteristics of the Staphylococcus aureus MepA multidrug efflux pump. J. Bacteriol. 195: 523-533.
63. Kumaraswami, M., J.T. Schuman, S.M. Seo, et al. 2009. Structural and biochemical characterization of MepR, a multidrug binding transcription regulator of the Staphylococcus aureus multidrug efflux pump MepA. Nucl. Acids Res. 37: 1211-1224.
64. Ohki, R. & M. Murata . 1997. bmr3, a third multidrug transporter gene of Bacillus subtilis. J. Bacteriol. 179: 1423-1427.
65. Klyachko, K.A., S. Schuldiner & A.A. Neyfakh . 1997. Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr. J. Bacteriol. 179: 2189-2193.
66. Gill, M.J., N.P. Brenwald & R. Wise . 1999. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43: 187-189.
67. Bolhuis, H., G. Poelarends, H.W. VanVeen, et al. 1995. The lactococcal lmrP gene encodes a proton motive force-dependent drug transporter. J. Biol. Chem. 270: 26092-26098.
68. Godreuil, S., M. Galimand, G. Gerbaud, et al. 2003. Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes. Antimicrob. Agents Chemother. 47: 704-708.
69. Boncoeur, E., C. Durmort, B. Bernay, et al. 2012. PatA and PatB form a functional heterodimeric ABC multidrug efflux transporter responsible for the resistance of Streptococcus pneumoniae to fluoroquinolones. Biochemistry 51: 7755-7765.
70. Escudero, J.A., M.A. San, B. Gutierrez, et al. 2011. Fluoroquinolone efflux in Streptococcus suis is mediated by SatAB and not by SmrA. Antimicrob. Agents Chemother. 55: 5850-5860.
71. VanVeen, H.W., A. Margolles, M. Müller, et al. 2000. The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism. EMBO J. 19: 2503-2514.
72. Guerin, F., M. Galimand, F. Tuambilangana, et al. 2014. Overexpression of the novel MATE fluoroquinolone efflux pump FepA in Listeria monocytogenes is driven by inactivation of its local repressor FepR. PLoS ONE. 9: e106340.
73. Li, X.Z., P. Plesiat & H. Nikaido . 2015. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. Rev. 28: 337-418.
74. Du, D., Z. Wang, N.R. James, et al. 2014. Structure of the AcrAB-TolC multidrug efflux pump. Nature 509: 512-515.
75. Nikaido, H. & Y. Takatsuka . 2009. Mechanisms of RND multidrug efflux pumps. Biochim. Biophys. Acta 1794: 769-781.
76. Yu, E.W., J.R. Aires & H. Nikaido . 2003. AcrB multidrug efflux pump of Escherichia coli: composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity. J. Bacteriol. 185: 5657-5664.
77. Yu, E.W., J.R. Aires, G. McDermott, et al. 2005. A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study. J. Bacteriol. 187: 6804-6815.
78. Li, X.Z. & H. Nikaido . 2004. Efflux-mediated drug resistance in bacteria. Drugs 64: 159-204.
79. Alekshun, M.N. & S.B. Levy . 1999. The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol. 7: 410-413.
80. Chou, J.H., J.T. Greenberg & B. Demple . 1998. Postranscriptional repression of Escherichia coli OmpF protein in response to redox stress: positive control of the micF antisense RNA by the soxRS locus. J. Bacteriol. 175: 1026-1031.
81. Miller, P.F., L. Gambino, M.C. Sulavik, et al. 1994. Genetic relationship between soxRS and mar loci in promoting multiple antibiotic resistance in Escherichia coli. Antimicrob. Agents Chemother. 38: 1773-1779.
82. Jair, K.W., X. Yu, K. Skarstad, et al. 1996. Transcriptional activation of promoters of the superoxide and multiple antibiotic resistance regulons by Rob, a binding protein of the Escherichia coli origin of chromosomal replication. J. Bacteriol. 178: 2507-2513.
83. Rosenberg, E.Y., D. Bertenthal, M.L. Nilles, et al. 2003. Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol. Microbiol. 48: 1609-1619.
84. Nikaido, H., K. Nikaido & S. Harayama . 1991. Identification and characterization of porins in Pseudomonas aeruginosa. J. Biol. Chem. 266: 770-779.
85. Li, X.Z., L. Zhang & K. Poole . 2000. Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. J. Antimicrob. Chemother. 45: 433-436.
86. Poole, K., K. Tetro, Q.X. Zhao, et al. 1996. Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob. Agents Chemother. 40: 2021-2028.
87. Poole, K., K. Krebes, C. McNally, et al. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175: 7363-7372.
88. Masuda, N., E. Sakagawa, S. Ohya, et al. 2000. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44: 3322-3327.
89. Li, X.Z., N. Barré & K. Poole . 2000. Influence of the MexA-MexB-OprM multidrug efflux system on expression of the MexC-MexD-OprJ and MexE-MexF-OprN multidrug efflux systems in Pseudomonas aeruginosa. J. Antimicrob. Chemother. 46: 885-893.
90. Köhler, T., M. Michea-Hamzehpour, P. Plesiat, et al. 1997. Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 41: 2540-2543.
91. Poole, K., N. Gotoh, H. Tsujimoto, et al. 1996. Overexpression of the mexC-mexD-oprJ efflux operon in nfxB- type multidrug-resistant strains of Pseudomonas aeruginosa. Mol. Microbiol. 21: 713-724.
92. Köhler, T., M. Michea-Hamzehpour, U. Henze, et al. 1997. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23: 345-354.
93. Westfall, L.W., N.L. Carty, N. Layland, et al. 2006. mvaT mutation modifies the expression of the Pseudomonas aeruginosa multidrug efflux operon mexEF-oprN. FEMS Microbiol. Lett. 255: 247-254.
94. Hay, T., S. Fraud, C.H. Lau, et al. 2013. Antibiotic inducibility of the mexXY multidrug efflux operon of Pseudomonas aeruginosa: involvement of the MexZ anti-repressor ArmZ. PLoS ONE. 8: e56858.
95. Matsuo, Y., S. Eda, N. Gotoh, et al. 2004. MexZ-mediated regulation of mexXY multidrug efflux pump expression in Pseudomonas aeruginosa by binding on the mexZ-mexX intergenic DNA. FEMS Microbiol. Lett. 238: 23-28.
96. Lomovskaya, O., K. Lewis & A. Matin . 1995. EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB. J. Bacteriol. 177: 2328-2334.
97. Yang, S., S.R. Clayton & E.L. Zechiedrich . 2003. Relative contributions of the AcrAB, MdfA and NorE efflux pumps to quinolone resistance in Escherichia coli. J. Antimicrob. Chemother. 51: 545-556.
98. Kim, H.B., M. Wang, C.H. Park, et al. 2009. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob. Agents Chemother. 53: 3582-3584.
99. Baucheron, S., H. Imberechts, E. Chaslus-Dancla, et al. 2002. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar typhimurium phage type DT204. Microb. Drug Resist. 8: 281-289.
100. Pradel, E. & J.M. Pagès . 2002. The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob. Agents Chemother. 46: 2640-2643.
101. Luo, N., O. Sahin, J. Lin, et al. 2003. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob. Agents Chemother. 47: 390-394.
102. Lin, J., L.O. Michel & Q.J. Zhang . 2002. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob. Agents Chemother. 46: 2124-2131.
103. +-driven multidrug efflux pump. J. Bacteriol. 182: 6694-6697.
104. Miyamae, S., H. Nikaido, Y. Tanaka, et al. 1998. Active efflux of norfloxacin by Bacteroides fragilis. Antimicrob. Agents Chemother. 42: 2119-2121.
105. Miyamae, S., O. Ueda, F. Yoshimura, et al. 2001. A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron. Antimicrob. Agents Chemother. 45: 3341-3346.
106. Fernando, D.M., W. Xu, P.C. Loewen, et al. 2014. Triclosan can select for an AdeIJK-overexpressing mutant of Acinetobacter baumannii ATCC 17978 that displays reduced susceptibility to multiple antibiotics. Antimicrob. Agents Chemother. 58: 6424-6431.
107. Yoon, E.J., P. Courvalin & C. Grillot-Courvalin . 2013. RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. Antimicrob. Agents Chemother. 57: 2989-2995.
108. Yoon, E.J., Y.N. Chabane, S. Goussard, et al. 2015. Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii. MBio. 6: e00309-e00315.
109. Zhang, L., X.Z. Li & K. Poole . 2001. SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 45: 3497-3503.
110. Alonso, A. & J.L. Martinez . 2000. Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 44: 3079-3086.
111. Martínez-Martínez, L., A. Pascual & G.A. Jacoby . 1998. Quinolone resistance from a transferable plasmid. Lancet 351: 797-799.
112. Robicsek, A. et al. 2006. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12: 83-88.
113. Yamane, K. et al. 2007. New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 51: 3354-3360.
114. Périchon, B., P. Courvalin & M. Galimand . 2007. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob. Agents Chemother. 51: 2464-2469.
115. Hansen, L.H. et al. 2007. Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria. J. Antimicrob. Chemother. 60: 145-147.
116. Tran, J.H. & G.A. Jacoby . 2002. Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. U S A. 99: 5638-5642.
117. Wang, M. et al. 2003. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 47: 2242-2248.
118. Cheung, T.K. et al. 2005. Plasmid-mediated resistance to ciprofloxacin and cefotaxime in clinical isolates of Salmonella enterica serotype Enteritidis in Hong Kong. J. Antimicrob. Chemother. 56: 586-589.
119. Jeong, J.Y. et al. 2005. Detection of qnr in clinical isolates of Escherichia coli from Korea. Antimicrob. Agents Chemother. 49: 2522-2524.
120. Jonas, D. et al. 2005. Plasmid-mediated quinolone resistance in isolates obtained in German intensive care units. Antimicrob. Agents Chemother. 49: 773-775.
121. Mammeri, H. et al. 2005. Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob. Agents Chemother. 49: 71-76.
122. Hata, M. et al. 2005. Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b. Antimicrob. Agents Chemother. 49: 801-803.
123. Jacoby, G.A. et al. 2006. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob. Agents Chemother. 50: 1178-1182.
124. Wang, M. et al. 2009. New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 53: 1892-1897.
125. Cavaco, L.M. et al. 2009. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob. Agents Chemother. 53: 603-608.
126. Fonseca, E.L. & A.C. Vicente . 2013. Epidemiology of qnrVC alleles and emergence out of the Vibrionaceae family. J. Med. Microbiol. 62: 1628-1630.
127. Pons, M.J., C. Gomes & J. Ruiz . 2013. QnrVC, a new transferable Qnr-like family. Enferm. Infecc. Microbiol. Clin. 31: 191-192.
128. Jacoby, G. et al. 2008. qnr gene nomenclature. Antimicrob. Agents Chemother. 52: 2297-2299.
129. Montero, C. et al. 2001. Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA. Antimicrob. Agents Chemother. 45: 3387-3392.
130. Hegde, S.S. et al. 2005. A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. Science. 308: 1480-1483.
131. Hegde, S.S. et al. 2011. Structural and biochemical analysis of the pentapeptide repeat protein EfsQnr, a potent DNA gyrase inhibitor. Antimicrob. Agents Chemother. 55: 110-117.
132. Xiong, X. et al. 2011. Structural insights into quinolone antibiotic resistance mediated by pentapeptide repeat proteins: conserved surface loops direct the activity of a Qnr protein from a gram-negative bacterium. Nucl. Acids Res. 39: 3917-3927.
133. Vetting, M.W. et al. 2011. Structure of QnrB1, a plasmid-mediated fluoroquinolone resistance factor. J. Biol. Chem. 286: 25265-25273.
134. Jacoby, G.A. et al. 2013. Mutational analysis of quinolone resistance protein QnrB1. Antimicrob. Agents Chemother. 57: 5733-5736.
135. Kumar, R., B.S. Madhumathi & V. Nagaraja . 2014. Molecular basis for the differential quinolone susceptibility of mycobacterial DNA gyrase. Antimicrob. Agents Chemother. 58: 2013-2020.
136. Willmott, C.J. & A. Maxwell . 1993. A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex. Antimicrob. Agents Chemother. 37: 126-127.
137. Shen, L.L. et al. 1989. Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes. J. Biol. Chem. 264: 2973-2978.
138. Mt and QnrB4 exhibit opposite effects on DNA gyrase catalytic reactions and on the ternary gyrase-DNA-quinolone complex. J. Bacteriol. 191: 1587-1594.
139. Tran, J.H., G.A. Jacoby & D.C. Hooper . 2005. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob. Agents Chemother. 49: 118-125.
140. Tavio, M.M., G.A. Jacoby & D.C. Hooper . 2014. QnrS1 structure-activity relationships. J. Antimicrob. Chemother. 69: 2102-2109.
141. Sánchez, M.B. et al. 2008. Predictive analysis of transmissible quinolone resistance indicates Stenotrophomonas maltophilia as a potential source of a novel family of Qnr determinants. BMC Microbiol. 8: 148-161.
142. Jacoby, G.A. & D.C. Hooper . 2013. Phylogenetic analysis of chromosomally determined Qnr and related proteins. Antimicrob. Agents Chemother. 57: 1930-1934.
143. Arsène, S. & R. Leclercq . 2007. Role of a qnr-like gene in the intrinsic resistance of Enterococcus faecalis to fluoroquinolones. Antimicrob. Agents Chemother. 51: 3254-3258.
144. Rodríguez-Martínez, J.M. et al. 2008. Qnr-like pentapeptide repeat proteins in gram-positive bacteria. J. Antimicrob. Chemother. 61: 1240-1243.
145. Shimizu, K. et al. 2008. Smqnr, a new chromosome-carried quinolone resistance gene in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 52: 3823-3825.
146. Sánchez, M.B. & J.L. Martínez . 2010. SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother. 54: 580-581.
147. Gordon, N.C. & D.W. Wareham . 2010. Novel variants of the Smqnr family of quinolone resistance genes in clinical isolates of Stenotrophomonas maltophilia. J. Antimicrob. Chemother. 65: 483-489.
148. Zhang, R. et al. 2012. Detection of the Smqnr quinolone protection gene and its prevalence in clinical isolates of Stenotrophomonas maltophilia in China. J. Med. Microbiol. 61: 535-539.
149. Poirel, L., V. Cattoir & P. Nordmann . 2012. Plasmid-mediated quinolone resistance; interactions between human, animal, and environmental ecologies. Front. Microbiol. 3: 24.
150. Poirel, L. et al. 2005. Vibrionaceae as a possible source of Qnr-like quinolone resistance determinants. J. Antimicrob. Chemother. 56: 1118-1121.
151. Poirel, L. et al. 2005. Origin of plasmid-mediated quinolone resistance determinant QnrA. Antimicrob. Agents Chemother. 49: 3523-3525.
152. Cattoir, V. et al. 2007. Vibrio splendidus as the source of plasmid-mediated QnrS-like quinolone resistance determinants. Antimicrob. Agents Chemother. 51: 2650-2651.
153. Jacoby, G.A., C.M. Griffin & D.C. Hooper . 2011. Citrobacter spp. as a source of qnrB alleles. Antimicrob Agents Chemother. 55: 4979-4984.
154. Zhang, R. et al. 2011. High prevalence of qnr and aac(6′)-Ib-cr genes in both water-borne environmental bacteria and clinical isolates of Citrobacter freundii in China. Microbes Environ. 27: 158-163.
155. Zhang, S. et al. 2013. Prevalence and plasmid characterization of the qnrD determinant in Enterobacteriaceae isolated from animals, retail meat products, and humans. Microb. Drug. Resist. 19: 331-335.
156. Guillard, T. et al. 2012. Description of a 2683-base-pair plasmid containing qnrD in two Providencia rettgeri isolates. Antimicrob. Agents Chemother. 56: 565-568.
157. Guillard, T. et al. 2014. Mobile insertion cassette elements found in small non-transmissible plasmids in Proteeae may explain qnrD mobilization. PLoS One 9: e87801.
158. Saga, T. et al. 2013. Characterization of qnrB-like genes in Citrobacter species of the American Type Culture Collection. Antimicrob. Agents Chemother. 57: 2863-2866.
159. Picão, R.C. et al. 2008. Plasmid-mediated quinolone resistance in Aeromonas allosaccharophila recovered from a Swiss lake. J. Antimicrob. Chemother. 62: 948-950.
160. Fonseca, E.L. et al. 2008. New qnr gene cassettes associated with superintegron repeats in Vibrio cholerae O1. Emerg. Infect. Dis. 14: 1129-1131.
161. Jacoby, G.A., J. Strahilevitz & D.C. Hooper . 2014. Plasmid-mediated quinolone resistance. Microbiol. Spectrum 2: PLAS-0006-2013.
162. Jeong, H.S. et al. 2011. Prevalence of plasmid-mediated quinolone resistance and its association with extended-spectrum beta-lactamase and AmpC beta-lactamase in Enterobacteriaceae. Korean J. Lab. Med. 31: 257-264.
163. Silva-Sanchez, J. et al. 2011. Prevalence and characterization of plasmid-mediated quinolone resistance genes in extended-spectrum β-lactamase-producing Enterobacteriaceae isolates in Mexico. Microb. Drug Resist. 17: 497-505.
164. Jlili Nel, H. et al. 2014. Trend of plasmid-mediated quinolone resistance genes at the Children's Hospital in Tunisia. J. Med. Microbiol. 63: 195-202.
165. Jacoby, G.A. et al. 2009. Temporal appearance of plasmid-mediated quinolone resistance genes. Antimicrob. Agents Chemother. 53: 1665-1666.
166. Zhao, X. et al. 2010. Decreased quinolone susceptibility in high percentage of Enterobacter cloacae clinical isolates caused only by Qnr determinants. Diagn. Microbiol. Infect. Dis. 67: 110-113.
167. Robicsek, A. et al. 2005. Broader distribution of plasmid-mediated quinolone resistance in the United States. Antimicrob. Agents Chemother. 49: 3001-3003.
168. Kim, H.B. et al. 2011. Cold shock induces qnrA expression in Shewanella algae. Antimicrob. Agents Chemother. 55: 414-416.
169. Wang, M. et al. 2009. SOS regulation of qnrB expression. Antimicrob. Agents Chemother. 53: 821-823.
170. Da Re, S. et al. 2009. The SOS response promotes qnrB quinolone-resistance determinant expression. EMBO Rep. 10: 929-933.
171. Briales, A. et al. 2012. Exposure to diverse antimicrobials induces the expression of qnrB1, qnrD and smaqnr genes by SOS-dependent regulation. J. Antimicrob Chemother. 67: 2854-2859.
172. Okumura, R. et al. 2011. Quinolone induction of qnrVS1 in Vibrio splendidus and plasmid-carried qnrS1 in Escherichia coli, a mechanism independent of the SOS system. Antimicrob. Agents Chemother. 55: 5942-5945.
173. Kwak, Y.G., G.A. Jacoby & D.C. Hooper . 2013. Induction of plasmid-carried qnrS1 in Escherichia coli by naturally occurring quinolones and quorum-sensing signal molecules. Antimicrob. Agents Chemother. 57: 4031-4034.
174. Vetting, M.W. et al. 2008. Mechanistic and structural analysis of aminoglycoside N-acetyltransferase AAC(6′)-Ib and its bifunctional fluoroquinolone-active AAC(6′)-Ib-cr variant. Biochemistry 47: 9825-9835.
175. Maurice, F. et al. 2008. Enzyme structural plasticity and the emergence of broad-spectrum antibiotic resistance. EMBO Rep. 9: 344-349.
176. Ruiz, E. et al. 2011. New genetic environments of aac(6′)-Ib-cr gene in a multiresistant Klebsiella oxytoca strain causing an outbreak in a pediatric intensive care unit. Diagn. Microbiol. Infect. Dis. 69: 236-238.
177. Ruiz, E. et al. 2012. qnr, aac(6′)-Ib-cr and qepA genes in Escherichia coli and Klebsiella spp.: genetic environments and plasmid and chromosomal location. J. Antimicrob. Chemother. 67: 886-897.
178. Musumeci, R. et al. 2012. Prevalence of plasmid-mediated quinolone resistance genes in uropathogenic Escherichia coli isolated in a teaching hospital of northern Italy. Microb. Drug Resist. 18: 33-41.
179. Ogbolu, D.O. et al. 2011. High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria. Int. J. Antimicrob. Agents. 37: 62-66.
180. Park, C.H. et al. 2006. Prevalence in the United States of aac(6′)Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob. Agents Chemother. 50: 3953-3955.
181. Pitout, J.D. et al. 2008. Surveillance for plasmid-mediated quinolone resistance determinants in Enterobacteriaceae within the Calgary Health Region, Canada: the emergence of aac(6′)-Ib-cr. J. Antimicrob. Chemother. 61: 999-1002.
182. Kim, E.S. et al. 2009. Prevalence of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea. Antimicrob. Agents Chemother. 53: 2643-2645.
183. Kim, H.B. et al. 2009. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob. Agents Chemother. 53: 639-645.
184. Guillard, T. et al. 2014. aac(6′)-IB-cr is the major plasmid-mediated quinolone resistance determinant in extended-spectrum β-lactamase-producing Escherichia coli in eastern France. J. Glob. Antimicrob. Resist. 2: 111-113.
185. Piekarska, K. et al. 2015. Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland. Int. J. Antimicrob. Agents. 45: 238-243.
186. Yamane, K. et al. 2008. Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan. Antimicrob. Agents Chemother. 52: 1564-1566.
187. Liu, J.H. et al. 2008. Coprevalence of plasmid-mediated quinolone resistance determinants QepA, Qnr, and AAC(6′)-Ib-cr among 16S rRNA methylase RmtB-producing Escherichia coli isolates from pigs. Antimicrob. Agents Chemother. 52: 2992-2993.
188. Périchon, B. et al. 2008. Sequence of conjugative plasmid pIP1206 mediating resistance to aminoglycosides by 16S rRNA methylation and to hydrophilic fluoroquinolones by efflux. Antimicrob. Agents Chemother. 52: 2581-2592.
189. Sorensen, A.H. et al. 2003. Conjugative plasmid conferring resistance to olaquindox. Antimicrob. Agents Chemother. 47: 798-799.
190. Hansen, L.H. et al. 2004. Plasmid-encoded multidrug efflux pump conferring resistance to olaquindox in Escherichia coli. Antimicrob. Agents Chemother. 48: 3332-3337.
191. Norman, A. et al. 2008. Nucleotide sequence of pOLA52: a conjugative IncX1 plasmid from Escherichia coli which enables biofilm formation and multidrug efflux. Plasmid 60: 59-74.
192. Kim, H.B. et al. 2009. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob. Agents Chemother. 53: 3582-3584.
193. Zhao, J. et al. 2010. Prevalence and dissemination of oqxAB in Escherichia coli Isolates from animals, farmworkers, and the environment. Antimicrob. Agents Chemother. 54: 4219-4224.
194. Wong, M.H. & S. Chen . 2013. First detection of oqxAB in Salmonella spp. isolated from food. Antimicrob. Agents Chemother. 57: 658-660.
195. Rodríguez-Martínez, J.M. et al. 2013. Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum-ß-lactamase-producing Klebsiella pneumoniae. J. Antimicrob. Chemother. 68: 68-73.
196. Li, L. et al. 2013. Spread of oqxAB in Salmonella enterica serotype Typhimurium predominantly by IncHI2 plasmids. J. Antimicrob. Chemother. 68: 2263-2268.
197. CTX-M genes in Escherichia coli isolates from food-producing animals. PLoS One 8: e73947.
198. Yuan, J. et al. 2012. Prevalence of the oqxAB gene complex in Klebsiella pneumoniae and Escherichia coli clinical isolates. J. Antimicrob. Chemother. 67: 1655-1659.
199. Perez, F. et al. 2013. OqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin. Antimicrob. Agents Chemother. 57: 4602-4603.
200. Andres, P. et al. 2013. Differential distribution of plasmid-mediated quinolone resistance genes in clinical enterobacteria with unusual phenotypes of quinolone susceptibility from Argentina. Antimicrob. Agents Chemother. 57: 2467-2675.
201. Veleba, M. et al. 2012. Characterization of RarA, a novel AraC family multidrug resistance regulator in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 56: 4450-4458.
202. DeMajumdar, S. et al. 2013. Elucidating the regulon of multidrug resistance regulator RarA in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 57: 1603-1609.
203. Hopkins, K.L., M. Day & E.J. Threlfall . 2008. Plasmid-mediated quinolone resistance in Salmonella enterica, United Kingdom. Emerg. Infect. Dis. 14: 340-342.
204. Campos, M.J. et al. 2014. Prevalence of quinolone resistance determinants in non-typhoida Salmonella isolates from human origin in Extremadura, Spain. Diagn. Microbiol. Infect. Dis. 79: 64-69.
205. Drlica, K. 2003. The mutant selection window and antimicrobial resistance. J. Antimicrob Chemother. 52: 11-17.
206. Jacoby, G.A. 2005. Mechanisms of resistance to quinolones. Clin. Infect. Dis. 41(Suppl 2): S120-126.
207. Rodríguez-Martínez, J.M. et al. 2007. Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. Antimicrob. Agents Chemother. 51: 2236-2239.
208. Wong, M.H. et al. 2014. PMQR genes oqxAB and aac(6′)Ib-cr accelerate the development of fluoroquinolone resistance in Salmonella typhimurium. Front. Microbiol. 5: 521.
209. Cesaro, A. et al. 2008. Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes. J. Antimicrob. Chemother. 61: 1007-1015.
210. Martínez-Martínez, L. et al. 2003. Interaction of plasmid and host quinolone resistance. J. Antimicrob. Chemother. 51: 1037-1039.
211. Briales, A. et al. 2011. In vitro effect of qnrA1, qnrB1, and qnrS1 genes on fluoroquinolone activity against isogenic Escherichia coli isolates with mutations in gyrA and parC. Antimicrob. Agents Chemother. 55: 1266-1269.
212. Luo, Y. et al. 2011. Joint effects of topoisomerase alterations and plasmid-mediated quinolone-resistant determinants in Salmonella enterica Typhimurium. Microb. Drug Resist. 17: 1-5.
213. Vinué, L. et al. 2014. Genetic analysis of enhanced quinolone resistance without gyrase mutations in Escherichia coli J53 pMG252 (qnrA1). Abst. 54th Intersci. Conf. Antimicrob. Agents Chemother.: abstr C-1429.
214. Jeong, J.Y. et al. 2008. Effects of a plasmid-encoded qnrA1 determinant in Escherichia coli strains carrying chromosomal mutations in the acrAB efflux pump genes. Diagn. Microbiol. Infect. Dis. 60: 105-107.
215. Sato, T. et al. 2013. Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutations. Front. Microbiol. 4: Doi: 10.3389/fmicb.2013.00125
216. Poirel, L. et al. 2007. Expanded-spectrum β-lactamase and plasmid-mediated quinolone resistance. Emerg. Infect. Dis. 13: 803-805.
217. Carattoli, A. 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53: 2227-2238.
218. Garza-Ramos, U. et al. 2012. Transfer of quinolone resistance gene qnrA1 to Escherichia coli through a 50 kb conjugative plasmid resulting from the splitting of a 300 kb plasmid. J. Antimicrob. Chemother. 67: 1627-1634.
219. Lascols, C. et al. 2008. A plasmid-borne Shewanella algae gene, qnrA3, and its possible transfer in vivo between Kluyvera ascorbata and Klebsiella pneumoniae. J. Bacteriol. 190: 5217-5223.
220. CMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a Tunisian burn unit. Antimicrob. Agents Chemother. 56: 1342-1349.
221. CTX-M-15 and qnrB1 genes. J. Antimicrob. Chemother. 67: 1645-1650.
222. Dolejska, M. et al. 2013. Plasmid content of a clinically relevant Klebsiella pneumoniae clone from the Czech Republic producing CTX-M-15 and QnrB1. Antimicrob. Agents Chemother. 57: 1073-1076.
223. Fortini, D. et al. 2009. Novel genetic environment of plasmid-mediated quinolone resistance gene qnrB2 in Salmonella Bredeney from poultry. J. Antimicrob. Chemother. 64: 1332-1334.
224. García-Fernández, A. et al. 2009. Characterization of plasmids harbouring qnrS1, qnrB2 and qnrB19 genes in Salmonella. J. Antimicrob. Chemother. 63: 274-281.
225. Jones-Dias, D. et al. 2013. Assessing the molecular basis of transferable quinolone resistance in Escherichia coli and Salmonella spp. from food-producing animals and food products. Vet. Microbiol. 167: 523-531.
226. DHA-1 and multiple antimicrobial resistance genes leading to increase of flomoxef resistance in extended-spectrum-ß-lactamase-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 55: 4058-4063.
227. Compain, F. et al. 2014. Complete nucleotide sequence of two multidrug-resistant IncR plasmids from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 58: 4207-4210.
228. Ma, J. et al. 2009. High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6′)-Ib-cr and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals. Antimicrob. Agents Chemother. 53: 519-524.
229. Fortini, D. et al. 2011. Plasmid-mediated quinolone resistance and β-lactamases in Escherichia coli from healthy animals from Nigeria. J. Antimicrob. Chemother. 66: 1269-1272.
230. Cattoir, V. et al. 2008. ISEcp1-mediated transposition of qnrB-like gene in Escherichia coli. Antimicrob. Agents Chemother. 52: 2929-2932.
231. Teo, J.W., K.Y. Ng & R.T. Lin . 2009. Detection and genetic characterisation of qnrB in hospital isolates of Klebsiella pneumoniae in Singapore. Int. J. Antimicrob. Agents 33: 177-180.
232. Chen, Y.T. et al. 2006. Complete nucleotide sequence of pK245, a 98-kilobase plasmid conferring quinolone resistance and extended-spectrum-beta-lactamase activity in a clinical Klebsiella pneumoniae isolate. Antimicrob. Agents Chemother. 50: 3861-3866.
233. Hu, F.P. et al. 2008. Coexistence of qnrB4 and qnrS1 in a clinical strain of Klebsiella pneumoniae. Acta pharmacologica Sinica 29: 320-324.
234. Carattoli, A. et al. 2010. Complete nucleotide sequence of the IncN plasmid pKOX105 encoding VIM-1, QnrS1 and SHV-12 proteins in Enterobacteriaceae from Bolzano, Italy compared with IncN plasmids encoding KPC enzymes in the USA. J. Antimicrob. Chemother. 65: 2070-2075.
235. CTX-M-1 and qnrS1 in equine Escherichia coli provide new insights into plasmid evolution. J. Antimicrob. Chemother. 69: 2388-2393.
236. Cattoir, V. et al. 2008. Unexpected occurrence of plasmid-mediated quinolone resistance determinants in environmental Aeromonas spp. Emerg. Infect. Dis. 14: 231-237.
237. Mazzariol, A. et al. 2012. Description and plasmid characterization of qnrD determinants in Proteus mirabilis and Morganella morganii. Clin. Microbiol. Infect. 18: E46-48.
238. Xia, R. et al. 2010. qnrVC-like gene located in a novel complex class 1 integron harboring the ISCR1 element in an Aeromonas punctata strain from an aquatic environment in Shandong Province, China. Antimicrob. Agents Chemother. 54: 3471-3474.
239. Woodford, N. et al. 2009. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob. Agents Chemother. 53: 4472-4482.
240. deToro, M. et al. 2013. pMdT1, a small ColE1-like plasmid mobilizing a new variant of the aac(6′)-Ib-cr gene in Salmonella enterica serovar Typhimurium. J. Antimicrob. Chemother. 68: 1277-1280.
241. Jiang, H.X. et al. 2014. Multiple transmissible genes encoding fluoroquinolone and third-generation cephalosporin resistance co-located in non-typhoidal Salmonella isolated from food-producing animals in China. Int. J. Antimicrob. Agents 43: 242-247.
242. Dotto, G. et al. 2014. High prevalence of oqxAB in Escherichia coli isolates from domestic and wild lagomorphs in Italy. Microb. Drug Resist. 20: 118-123.
243. CTX-M-negative Escherichia coli isolates from food-producing animals. Microb. Drug Resist. 20: 641-650.
244. Cattoir, V., L. Poirel & P. Nordmann . 2008. Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrob. Agents Chemother. 52: 3801-3804.
245. Périchon, B. et al. 2008. Sequence of conjugative plasmid pIP1206 mediating resistance to aminoglycosides by 16S rRNA methylation and to hydrophilic fluoroquinolones by efflux. Antimicrob. Agents Chemother. 52: 2581-25922592.